SCHEMBL3260918

SCHEMBL3260918

Cn1cc(OC(N)=O)cn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 2/20 0.42
MKNK2 Q9HBH9 2/20 0.42
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MAP4K4 O95819 1/20 0.38
PLAU P00749 1/20 0.35
GRM2 Q14416 1/20 0.35
LCK P06239 1/20 0.34
BTK Q06187 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CCNC P24863 1/20 0.34
CDK8 P49336 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
CYP11B2 P19099 1/20 0.34
FGFR2 P21802 1/20 0.33
FGFR3 P22607 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL28546613 0.89 MET (0.39) MKNK1MKNK2MEN1KMT2AALDH1A1
SCHEMBL248731 0.82 L3MBTL1 (0.39) MKNK1MKNK2MEN1KMT2AALDH1A1
SCHEMBL27919008 0.82 LMNA (0.41) MKNK1MKNK2MEN1KMT2AALDH1A1
SCHEMBL21188221 0.81 SMN1; SMN2 (0.41) MKNK1MKNK2MEN1KMT2AALDH1A1
SCHEMBL15671544 0.79 SMN1; SMN2 (0.40) MKNK1MKNK2MEN1KMT2AALDH1A1
SCHEMBL11183659 0.78 KDM4E (0.40) MEN1KMT2AALDH1A1HTTSMN1; SMN2
SCHEMBL27550332 0.78 THRB (0.40) MKNK1MKNK2MEN1KMT2AALDH1A1
SCHEMBL11003322 0.78 L3MBTL1 (0.53) MEN1KMT2AALDH1A1HTTSMN1; SMN2
SCHEMBL11002480 0.77 KMT2A (0.36) MEN1KMT2AHTTSMN1; SMN2
SCHEMBL22723808 0.77 PDK2 (0.45) MKNK1MKNK2MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112654605-B Bridged heterocyclic group substituted pyrimidine compound and preparation method and medical application thereof 中国医药研究开发中心有限公司 2022-11-22 CN disclosed
CN-112654605-A Bridged heterocyclic group substituted pyrimidine compound and preparation method and medical application thereof 中国医药研究开发中心有限公司 2021-04-13 CN disclosed
WO-2021027647-A1 BRIDGED HETEROCYCLYL-SUBSTITUTED PYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL USE THEREOF 中国医药研究开发中心有限公司 2021-02-18 WO disclosed
CN-111954670-A Sulfonylurea derivatives as NLRP3 inflammasome modulators 诺瑟拉有限公司 2020-11-17 CN disclosed
CN-107207509-B Substituted bridged ring urea analogs as sirtuin modulators 葛兰素史密斯克莱知识产权(第2 号)有限公司 2020-04-21 CN disclosed
CN-110627775-A Small molecule compound 嘉兴特科罗生物科技有限公司 2019-12-31 CN disclosed
WO-2014111871-A1 4,5-DIHYDROISOXAZOLE DERIVATIVES AS NAMPT INHIBITORS AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2014-07-24 WO disclosed
EP-2455098-A1 New cyclic peptide compounds Astellas Pharma Inc. (JP) 2012-05-23 EP disclosed
EP-2150269-A1 NEW CYCLIC PEPTIDE COMPOUNDS Astellas Pharma Inc. (JP) 2010-02-10 EP disclosed
WO-2009135865-A1 PROCESS FOR THE PRODUCTION OF PARTICLES COMPRISING ACTIVE AGROCHEMICAL INGREDIENTS IN AMORPHOUS FORM BASF SE (DE) 2009-11-12 WO disclosed
WO-2008139986-A1 NEW CYCLIC PEPTIDE COMPOUNDS ASTELLAS PHARMA INC., (JP) 2008-11-20 WO disclosed
US-4513000-A Insecticidal N-substituted O-pyrazol-4-yl carbamates and use thereof BAYER AKTIENGESELLSCHAFT (DE) 1985-04-23 US disclosed